NCT Number: NCT01978704
Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients
The aim of this study is to compare the feasibility and the efficacy on short-term glucose control of pre-meal insulin doses adjustment made on the bases of the glycemic load or of the carbohydrates content of the meal in patients with type 1 diabetes mellitus treated with insulin pump
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Type 1 diabetes treated by insulin pump
Exclusion criteria
- Preganncy
- HbA1c > 9%
- Any serious acute or chronic illness a part diabetes
Treatment and study plan
Adjustment of pre-prandial insulin doses on the bases of carbohydrates content of the meal
OtherPrimary outcomes
-
daily plasma glucose excursion
Time frame: 1 week
-
mean plasma glucose concentrations
Time frame: 1 week
Secondary outcomes
-
postprandial plasma glucose concentrations
Time frame: 1 week
Sponsors and collaborators
Lead sponsor
Federico II University
Other
Registry information
Official study title
Use of the Glycemic Load for the Adjustment of the Dose of Preprandial Insulin in Patients With Type 1 Diabetes Mellitus in Insulin Pump Therapy
Acronym: GLUT
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Nov 7, 2013
- Registry last updated
- Nov 7, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes
NCT05488119
Autoimmune Diseases, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsDiabetes Management Among Women Using an AID System: a Mixed Method Study
NCT07696780
Autoimmune Diseases, Diabetes Mellitus
Bern, Canton of Bern, Switzerland
View Trial DetailsAdaptive Biobehavioral Control (ABC) in a Closed-Loop System
NCT05610111
Autoimmune Diseases, Diabetes Mellitus
Charlottesville, Virginia, United States
View Trial DetailsMyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)
NCT06308549
Autoimmune Diseases, Diabetes Distress
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial Details